Research Article: Invasive Breast Cancer with HER ?. and <.: Risk Classification and Molecular Typing by a -Gene Expression Assay and MammaPrint Plus BluePrint Testing
Introduction:
Human epidermal growth factor receptor (HER) gene amplification and protein expression are reported in approximately –% of breast cancers and are well known associated with poor prognosis and benefit from anti-HER targeted therapy. – Therefore, the accurate determination of HER status in invasive breast cancer is of utmost importance.
Read more